Evidence map›Paper›PMID 42490015›Full record

ReviewPharmacoEconomics2026

Uncertainty in Economic Evaluation: A Pragmatic Guide for Health Technology Assessment (HTA) Agencies in Resource-Constrained Settings.

Siobhan Botwright, Syarifah Liza Munira, Itamar Megiddo, Nouran El Desouky, Lucky Gift Ngwira, Hugo C Turner, Yot Teerawattananon

Abstract readReview
PubMed Publisher
In one paragraph

Review in PharmacoEconomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siobhan BotwrightHealth Intervention and Technology Assessment Program Foundation, Nonthaburi, Thailand. Siobhan.b@hitap.net.ORCID http://orcid.org/0000-0002-8204-2065
Syarifah Liza MuniraDepartment of Economics, Faculty of Economics and Business, Universitas Indonesia, Jakarta, Indonesia.ORCID http://orcid.org/0000-0003-3359-4290
Itamar MegiddoCentre for Health Economics, University of York, York, UK.ORCID http://orcid.org/0000-0001-8391-6660
Nouran El DesoukyMinistry of Finance, Cairo, Egypt.ORCID http://orcid.org/0000-0001-6938-8996
Lucky Gift NgwiraHealth Economics and Policy Unit, Kamuzu University of Health Sciences, Blantyre, Malawi.ORCID http://orcid.org/0000-0002-2695-8917
Hugo C TurnerMRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-8428-3874
Yot TeerawattananonHealth Intervention and Technology Assessment Program Foundation, Nonthaburi, Thailand.ORCID http://orcid.org/0000-0003-2217-2930

Funding

MRC Centre for Global Infectious Disease Analysis MR/R015600/1National Science, Research and Innovation Fund (NSRF) through the Program Management Unit for Human Resources & Institutional Development, Research and Innovation B41G670025National Science, Research and Innovation Fund (NSRF) through the Program Management Unit for Human Resources & Institutional Development, Research and Innovation B41G680024
6 · The paper itself

Abstract

Understanding the financial and health consequences if economic evaluation assumptions prove incorrect is essential for managing the risk associated with benefit package decisions, particularly in resource-constrained and overburdened healthcare systems. Yet these are also the settings that face the greatest challenges in conducting comprehensive uncertainty analysis, owing to a range of factors including limited skilled staff, data constraints, and short timelines to generate evidence in time to influence policy. This paper takes a pragmatic approach to support health technology assessment agencies in these settings to generate policy-relevant uncertainty analysis, drawing on good practice literature and the authors' collective experience conducting economic evaluation for policy across resource-constrained settings. For each step of the economic evaluation process, we outline the main sources of uncertainty, principles for deciding which uncertainty analysis to prioritise, and approaches to overcome some of the common challenges faced when dealing with constrained timelines, data, and skilled staff. The overarching goal is to support better-informed decisions, by targeting uncertainty analysis to factors that actually affect decisions and by effectively communicating this decision-relevant uncertainty to policymakers.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.